Shareholding for the Period Ended June 30, 2018
JMD Ventures Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here14-07-2018
14-07-2018
Revised Financial Results For The Year Ended March 31, 2018
Enclosed is revised Financial Results for QE/YE March 31, 2018 together with Audit Report for consolidated results which was missing in earlier submission and has been included now without change in any of figures in comparison to our earlier submission.25-06-2018
Announcement under Regulation 30 (LODR)-Updates on Joint Venture
Members are hereby informed that the M/s. JMD Medicos Limited, Subsidiary of M/s. JMD Ventures Limited has entered into strategic agreement with M/s. Neolab Biotech Industries, a proprietorship firm for an investment of Rs. 100.00 Lakh into the Company with a profit sharing to the extent of 95% of net profit of said firm. M/s. Neolab Biotech Industries is into the business of ayurvedic medicine production was a supplier to the Company prior to entering into the agreement.30-05-2018
Audited Financial Results For The Quarter And Year Ended March 31, 2018
We are enclosing herewith Standalone and Consolidated Audited financial results for the Quarter and year ended March 31, 2018 together with Statement of Assets & Liabilities, Audit Report and Declaration in respect of Audit Report with unmodified opinion under Regulation 33 of Listing Regulations.30-05-2018
Shareholding for the Period Ended March 31, 2018
JMD Ventures Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here20-04-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached copy of Press Release titled as - JMD Medico launches JEMP New mentoring program to fast-track entrepreneurs in the country An entrepreneur can earn up to INR 50,000 each month for one of its subsidiary M/s. JMD Medico Services Limited which will be disseminated shortly. Contents of Press Release are self-explanatory. This is for the information of Members.11-04-2018
Compliance Certificate U/R 7(3) For The Period Ended 31St March 2018
We are enclosing along with this letter, Certificate u/r 7(3) of SEBI LODR Regulations 2015, duly signed by RTA and Compliance Officer of the Company for the half year ended on 31st March 2018.11-04-2018
PCS Certificate U/R 40(10) Of SEBI LODR Regulations 2015 For Half Year Ended March 31, 2018
We are enclosing along with this letter, certificate for half year ended on 31st March 2018; issued & certified by M/s. G. S. Bhide & Associates, Practicing Company Secretaries; u/r 40(9) & (10) of SEBI LODR Regulations, 2015.06-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Kailash Prasad PurohitDesignation :- Director04-04-2018